Gazi University Dspace
Not a member yet
26981 research outputs found
Sort by
The geographical distribution of morbidity caused by chronic obstructive pulmonary disease in Turkey: COPDTURKEY-2
No full text
Correction to: On the use of hierarchical fuzzy inference systems (HFIS) in expert-based landslide susceptibility mapping: the central part of the Rif Mountains (Morocco) (Bulletin of Engineering Geology and the Environment, (2020), 79, 1, (551-568), 10.1007/s10064-019-01548-5)
No full textInvestigation of cold extrusion process by coupled thermo-mechanical finite element analysis [Soğuk ekstrüzyon prosesinin termo-mekanik bağlı sonlu elemanlar analizi ile incelenmesi]
No full textINVESTIGATION OF HISTAMINE LEVELS IN PASTEURIZED, HIGH HEAT-TREATED MILK AND TYPES OF CHEESE
No full textThe Effect of Cerium Oxide on Lung Tissue in Lower Extremity Ischemia Reperfusion Injury in Sevoflurane Administered Rats
No full text
Ethical dilemmas that school administrators and teachers experience: Reasons and coping strategies
No full textClinical features and outcomes of COVID-19 in patients with solid tumors: Turkish National Registry Data
No full textWe present demographic, clinical, laboratory characteristics and
outcomes of the patients with solid malignancies and novel coronavirus
disease (COVID-19) collected from the National COVID-19 Registry of
Turkey. A total of 1523 patients with a current or past diagnosis of
solid tumors and diagnosed with COVID-19 (confirmed with PCR) between 11
March and 20 May 2020 were included. The primary outcome was 30-day
mortality. Median age was 61 (range: 18-94), and 752 (49\%) were male.
The most common types of cancers were breast (19.8\%), prostate (10.9\%)
and colorectal cancer (10.8\%). 65\% of the patients had at least one
comorbidity. At least one COVID-19-directed therapy was given in 73\% of
the patients.. Hospitalization rate of the patients was 56.6\% and
intensive care unit admission rate was 11.4\%. Seventy-seven (5.1\%)
patients died within 30 days of diagnosis. The first multivariate model
which included only the demographic and clinical characteristics showed
older age, male gender and presence of diabetes and receipt of cytotoxic
therapy to be associated with increased 30-day mortality, while breast
and prostate cancer diagnoses were associated with lower 30-day
mortality. In the second set, we further included laboratory parameters.
The presence of leukocytosis (OR 6.7, 95\% CI 3.3-13.7, P < .001),
lymphocytopenia (OR 3,1, 95\% CI 1,6-6,1, P = .001) and thrombocytopenia
(OR 3,4 95\% CI 1,5-8,1, P = .005) were found to be associated with
increased 30-day mortality. Relatively lower mortality compared to
Western countries and China mainly results from differences in baseline
risk factors but may also implicate the importance of intensive
supportive care
